“Working at PepGen is full of fun and exciting moments. Knowing our work can deliver transformative treatments to people affected by serious muscle disease, like DMD and Dm1, is even more satisfying”
PepGen
Biotechnology Research
Boston, Massachusetts 8,961 followers
Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.
Meet our Leaders
Our Story
The culmination of a decade of work by pioneering researchers and biotech leaders has created our revolutionary Enhanced Delivery Oligonucleotide (EDO) platform allowing us to build a pipeline of therapeutics to treat a range of devastating diseases. We are currently advancing two programs towards the clinic: one for DMD patients treatable with an exon 51 skipping oligonucleotide and the other targeting myotonic dystrophy type 1 (DM1), both rare genetic diseases with a high unmet medical need.
Our Culture
At PepGen, science is at the heart of everything we do. By using our technology to harness the power of enhanced delivery peptides and overcome the delivery challenges associated with current nucleic acid therapeutics, we can develop transformative therapeutics for those in need. Driven by integrity and a deep commitment to the neuromuscular disease community, we use evidence-based research to develop groundbreaking, innovative therapies.
Our Core Values
Research - We are a scientific company at heart, and we approach our work with an evidence-based mindset. Innovation - We are always exploring new ways to learn, build and improve across all facets of our company. Integrity - We act ethically and honestly in both our science and our business. Responsibility - As a therapeutic company, we appreciate the impact our work has on people and their families.
Careers